Generation of DOPA-producing astrocytes by retroviral transduction of the human tyrosine hydroxylase gene: In vitro characterization and in vivo effects in the rat Parkinson model

Experimental Neurology

Volumn 139, Issue 1, 1996, Pages 39-53

  Lundberg, Cecilia ^a   Horellou, Philippe ^b   Mallet, Jacques ^b   Björklund, Anders ^a  

^a LUND UNIVERSITY   (Sweden)

^b CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DOPA; GLIAL FIBRILLARY ACIDIC PROTEIN; OXIDOPAMINE; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL CULTURE; CELL TRANSPLANTATION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; EMBRYO; FEMALE; GENE TRANSFER; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; RETROVIRUS;

EID: 0029973056     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1996.0079     Document Type: Article

References (42)

1. ANTON, R., J. H. KORDOWER, N. T. MAIDMENT, J. S. MANASTER, D. J. KANE, S. RABIZADEH, S. B. SCHUELLER, J. YANG, S. RABIZADEH, R. H. EDWARDS, C. H. MARKHAM, AND D. E. BREDESEN. 1994. Neural-targeted gene therapy for rodent and primate hemiparkinsonsim. Exp. Neurol. 127: 207-218.
2. ARMETANO, D., S.-F. YU, P. W. KANTOFF, T. VON RUDEN, W. F. ANDERSON, AND E. GILBOA. 1987. Effect of internal viral sequences on the utility of retroviral vectors. J. Virol. 61: 1647-1650.
3. BERNSTEIN, J. J., AND W. J. GOLDBERG. 1989. Rapid migration of grafted cortical astrocytes from suspension grafts placed in the thoracic spinal cord. Brain Res. 491: 205-211.
4. CHENG, D., AND H. OKAYAMA. 1987. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7: 2745-2752.
5. CUNNIGHAM, L. A., J. T. HANSEN, M. P. SHORT, AND M. C. BOHN. 1991. The use of genetically altered astrocytes to provide nerve growth factor to adrenal chromaffin cells grafted into the striatum. Brain Res. 561: 192-202.
6. DURING, M. J., J. R. NAEGELE, K. L. O'MALLEY, AND A. I. GELLER. 1994. Long-term behavioural recovery in Parkinsonian rats by an HSV vector expressing tyrosine hydroxylase. Science 266: 1399-1403.
7. EMMET, C. J., J. M. LAWRENCE, AND P. J. SEELEY. 1988. Visualization of migration of transplanted astrocytes using polystyrene microspheres. Brain Res. 447: 223-233.
8. EMMET, C. J., J. M. LAWRENCE, G. RAISMAN, AND P. J. SEELEY. 1991. Cultured epitheloid astrocytes migrate after transplantation into the adult rat brain. J. Comp. Neurol. 310: 330-341.
9. FISHER, L. J., H. A. JINNAH, L. C. KALE, G. A. HIGGINS, AND F. H. GAGE. 1991. Survival and function of intrastriatally grafted primary fibroblasts genetically modified to produce L-DOPA. Neuron 6: 371-380.
10. HORELLOU, P., B. LE BOURDELLES, J. CLOT-HUMBERT, B. GUIBERT, V. LEVIEL, AND J. MALLET. 1988. Multiple human tyrosine hydroxylase enzymes, generated through alternative splicing, have different specific activities in Xenopous oocytes. J. Neurochem. 51: 652-655.
11. HORELLOU, P., B. GUIBERT, V. LEVIEL, AND J. MALLET. 1989. Retroviral transfer of a human tyrosine hydroxylase cDNA in various cell lines: Regulated release of dopamine in mouse anterior pituitary AtT-20 cells. Proc. Natl. Acad. Sci. USA 86: 7233-7237.
12. HORELLOU, P., L. MARLIER, A. PRIVAT, AND J. MALLET. 1990. Behavioural effect of engineered cells that synthesize L-DOPA or dopamine after grafting into the rat neostriatum. Eur. J. Neurosci. 2: 116-119.
13. HORELLOU, P., P. BRUNDIN, P. KALÉN, J. MALLET, AND A. BJÖRKLUND. 1990. In vivo release of DOPA and dopamine from genetically engineered cells grafted to the denervated rat striatum. Neuron 5: 393-402.
14. HORELLOU, P., E. VIGNE, M. CASTEL, P. BARNÉOUD, P. COLIN, M. PERRICAUDET, DELAÈRE AND J. MALLET. 1994. Direct intracerebral gene transfer of an adenoviral vector expressing tyrosine hydroxylase in a rat model of Parkinson's disease. NeuroReport 5: 49-53.
15. JAQUES, C. M., I. M. SUARD, V. P. COLLINS, AND M. M. RAOL. 1986. Interspecies identification of astrocytes after intracerebral transplantation. Dev. Neurosci. 8: 142-149.
16. JACQUE, C., J. QUINONERO, P. V. COLLINS, VILLAROYA AND I. SUARD. 1992. Comparative migration and development of astroglial and olidendroglial cell populations from a brain xenograft. J. Neurosci. 12: 3098-3106.
17. JIAO, S., V. GUREVICH, AND J. A. WOLFF. 1993. Long-term correction of rat model of Parkinson's disease by gene therapy. Nature 362: 450-453.
18. KAPLITT, M. G., P. LEONE, R. J. SAMULISKI, X. XIAO, D. W. PFAFF, K. L. O'MALLEY, AND M. J. DURING. 1994. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in mammalian brain. Nature Genet. 8: 148-154.
19. LA GAMMA, E. F., R. E. STRECKER, N. J. LENN, J. D. DECRISTOFARO, AND G. WEISINGER. 1994. Dopaminergic regulation of a transfected preproenkephalin promoter in primary rat astrocytes in vitro and in vivo. Exp. Neurol. 130: 304-310.
20. LA GAMMA, E. F., G. WIESINGER, N. J. LENN, AND R. E. STRECKER 1993. Genetically modified primary astrocytes as cellular vehicles for gene therapy in the brain. Cell Transplant. 2: 207-214.
21. LEVISON, S. W., AND K. D. MCCARTHY. 1991. Astroglia in culture. Pages 309-336. in G. Banker and K. Goslin, Eds., Culturing Nerve Cells. MIT Press, Cambridge, MA.
22. LINDSAY, R. M., C. EMMET, G. RAISMAN, AND P. J. SEELEY. 1987. Application of tissue culture and cell-marking techniques to the study of neural transplants. Ann. NY Acad. Sci. 495: 35-52.
23. MELAMED, E., F. HEFTI, AND R. J. WURTMAN. 1980. Non-aminergic striatal neurons convert exogenous L-DOPA to dopamine in Parkinsonism. Ann. Neurol. 8: 558-563.
24. MELAMED, E., AND F. HEFTI. 1984. Mechanism of action of short-and long-term L-DOPA treatment in Parkinsonism: Role of the surviving nigrostriatal dopaminergic neurons. Adv. Neurol. 40: 149-157.
25. MUCKE, L., AND E. M. ROCKENSTEIN. 1993. Prolonged delivery of transgene products to specific brain regions by migratory astrocyte grafts. Transgenics 1: 3-9.
26. MULLIGAN, R. C. 1993. The basic science of gene therapy. Science 260: 926-932.
27. PAXINOS, G., AND C. WATSON. 1986. The Rat Brain in Stereotaxic Coordinates. Academic Press, San Diego.
28. 3H]-tyrosine by charcoal. Life Sci. 39: 2185-2189.
29. RIDOUX, V., J. J. ROBERT, X. ZHANG, M. PERRICAUDET, J. MALLET, AND G. LE GAL LA SALLE. 1994. The use of adenovirus vectors for intracerebral grafting of transfected nervous cells. NeuroReport 5: 801-804.
30. SCHINSTINE, M., M. B. ROSENBERG, C. ROUTLEDGE-WARD, T. FRIEDMANN, AND F. H. GAGE. 1992. Effects of choline and quiescence on Drosophila choline acetyltransferase expression and acetycholine production by transduced rat fibroblasts. J. Neurochem. 58: 2019-2029.
31. 14C]2-deoxy-D-glucose autoradiography. J. Neurochem. 38: 737-748.
32. SCHUENING, F. G., R. STORB, R. B. STEAD, GOEHLE, R. NASH, AND A. D. MILLER 1989. Improved retroviral transfer of genes into canine progenitor cells kept in long-term marrow culture. Blood 74: 152-155.
33. SMITH, G. M., AND J. SILVER. 1988. Transplantation of immature and mature astrocytes and their effect on scar formation in the lesioned central nervous system. Prog. Brain Res. 78: 192-208.
34. SMITH, G. M., AND R. H. MILLER. 1991. Immature type-1 astrocytes suppress glial scar formation, are motile and interact with blood vessels. Brain Res. 543: 111-122.
35. UCHIDA, K., K. TAKAMATSU, N. KANEDA, S. TOYA, Y. TSUKADA, Y. KUROSAWA, K. FUJITA, AND S. KOHSAKA. 1989. Synthesis of L-3,4-dihydroxyphenylalanine by tyrosine hydroxylase cDNA-transfected C6 cells: Application for intracerebral grafting. J. Neurochem. 53: 728-732.
36. UCHIDA, K., A. ISHII, N. KANEDA, S. TOYA, T. NAGATSU, AND S. KOHSAKA. 1990. Tetrahydrobiopterin-dependent production of L-DOPA in NRK fibroblasts transfected with tyrosine hydroxylase cDNA: Future use for intracerebral grafting. Neurosci. Lett. 109: 282-286.
37. UCHIDA, K., N. TSUZAKI, T. NAGATSU, AND S. KOHSAKA. 1992. Tetrahydrobiopterin-dependent functional recovery in 6-hydroxydopamine-treated rats by intracerebral grafting of fibroblasts transfected with tyrosine hydroxylase cDNA. Dev. Neurosci. 14: 173-180.
38. UNGERSTEDT, U., AND G. W. ARBUTHNOTT. 1970. Quantitative recording of rotational behaviour in rats after 6-hydroxydopamine lesions of the nigrostriatal dopamine system. Brain Res. 24: 485-493.
39. VAN BEUSECHEM, V. W., T. A. BAKX, L. C. KAPTEIN, J. A. K. BART-BAUMEISTER, A. KUKLER, E. BRAAKMAN, AND D. VALERIO. 1993. Retrovirus-mediated gene transfer into Rhesus monkey hematopoetic stem cells: The effect of viral titers on transduction efficiency. Hum. Gene. Ther. 4: 239-247.
40. WOLFF, J. F., L. J. FISHER, L. XU, H. A. JINNAH, P. J. LANGLAIS, P. M. IUVONE, K. L. O'MALLEY, M. B. ROSENBERG, S. SHIMOHAMA, T. FRIEDMANN, AND F. H. GAGE. 1989. Grafting fibroblasts genetically modified to produce L-DOPA in a rat model of Parkinson's disease. Proc. Natl. Acad. Sci. USA 86: 9011-9014.
41. XU, L., J.-K. YEE, J. A. WOLFF, AND T. FRIEDMANN. 1989. Factors affecting long-term stability of Moloney murine leukemia virus-based vectors. Virology 171: 331-341.
42. ZHOU, H., AND R. D. LUND. 1993. Effects of the age of donor or host tissue on astrocyte migration from intracerebral xenografts of corpus callosum. Exp. Neurol. 122: 155-164.